A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer-Reference-Cited by-同舟云学术

A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer

Published:2013-08-03 Issue:3 Volume:72 Page:637-642
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Chao Yee,Wu Chen-Yi,Wang Jack P.,Lee Rheun-Chuan,Lee Wei-Ping,Li Chung-Pin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-013-2239-1.pdf

Reference24 articles.

1. Jemal A, Siegel R, Xu J et al (2010) (2010) Cancer statistics. CA Cancer J Clin 60(5):277–300

2. American Cancer Society. Survival rates for pancreatic cancer. http://www.cancer.org/Cancer/PancreaticCancer/OverviewGuide/pancreatic-cancer-overview-survival-rates

3. Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403–2413

4. Storniolo AM, Enas NH, Brown CA et al (1999) An investigational new drug treatment program for patients with gemcitabine: results for over 3,000 patients with pancreatic carcinoma. Cancer 85(6):1261–1268

5. Eastman A (1987) The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther 34(2):155–166

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of cisplatin and ethyl acetate extract of Vernonia amygdalina Delile induces cell cycle arrest and apoptosis on PANC-1 cells via PI3K/mTOR;Journal of Pharmacy & Pharmacognosy Research;2024-09-01

2. Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer;Pancreatology;2024-03

3. Efficacy of Cisplatin-Containing Chemotherapy Regimens in Patients of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis;Journal of Gastrointestinal Cancer;2024-02-05

4. A meta-analysis and systematic review of randomized controlled trials in combination Gemcitabine with Erlotinib in the pancreatic cancer;2023-11-11

5. The efficacy and safety of gemcitabine-based combination therapy vs. gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis;Journal of Gastrointestinal Oncology;2022-08